Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Tacrolimus and pimecrolimus. Introduction

L F Eichenfield¹

¹Children's Hospital, San Diego, CA, USA.

Seminars in Cutaneous Medicine and Surgery

|January 5, 2002

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Estimands for atopic dermatitis clinical trials: Expert opinion on the importance of intercurrent events.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023

Same author

Topical therapy of atopic dermatitis with a focus on pimecrolimus.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021

Same author

Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase III trials.

The Journal of dermatological treatment·2020

Same author

A position paper on the management of itch and pain in atopic dermatitis from the International Society of Atopic Dermatitis (ISAD)/Oriented Patient-Education Network in Dermatology (OPENED) task force.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020

Same author

Dupilumab provides favourable long-term safety and efficacy in children aged ≥ 6 to < 12 years with uncontrolled severe atopic dermatitis: results from an open-label phase IIa study and subsequent phase III open-label extension study.

The British journal of dermatology·2020

Same author

Ustekinumab for the treatment of moderate-to-severe plaque psoriasis in paediatric patients (≥ 6 to < 12 years of age): efficacy, safety, pharmacokinetic and biomarker results from the open-label CADMUS Jr study.

The British journal of dermatology·2020